Web Analytics

3 Latest Announced Rounds

$2,242.25M Raised in 70 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Actym Therapeutics, Inc.

start up
United States - Berkeley, CA
  • 20/10/2023
  • Series A
  • $59,500,000

Actym Therapeutics is a cutting-edge biotech focused on the discovery and development of novel immuno-oncology therapies.


Related People

Christopher ThanosCo Founder

Christopher Thanos United States - Belvedere Tiburon, California

• Significant entrepreneurial and leadership experience in the biotechnology industry
• 30 years R&D experience
• Design, engineering, and production of cell therapies, ADC's, enzymes, and alternative scaffolds
• Comprehensive understanding of pipeline flow, from lead optimization to IND, to clinical POC
• Established skills in competitive intelligence, strategy, due diligence, portfolio management
• Inventor on multiple issued patents covering biotherapeutics
• First author publications in high impact factor journals such as Science, PNAS, JACS
• Effectively managed large teams
• Invited speaker, workshop leader, conference chair at several international meetings